High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome

Published:2020-07 Issue:7 Volume:15 Page:1232-1239
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Mezquita Laura,Jové Maria,Nadal Ernest,Kfoury Maria,Morán Teresa,Ricordel Charles,Dhooge Marion,Tlemsani Camille,Léna Hervé,Teulé Alex,Álvarez Jose-Valero,Raimbourg Judith,Hiret Sandrine,Lacroix Ludovic,Menéndez Mireia,Saldaña Juana,Brunet Joan,Lianes Pilar,Coupier Isabelle,Auclin Edouard,Recondo Gonzalo,Friboulet Luc,Adam Julien,Green Emma,Planchard David,Frébourg Thierry,Capellà Gabriel,Rouleau Etienne,Lázaro Conxi,Caron Olivier,Besse Benjamin

Funder

Bristol-Myers Squibb

Boehringer Ingelheim

Roche

Pfizer

MSD

Lilly

AstraZeneca

Novartis

Pierre Fabre

Amgen

Takeda

IPSEN)

IPSEN

ADACAP

Merck

MedImmune

Sanofi

Taiho Pharma

Novocure

Gustave Roussy Cancer Center

Abbvie

Biogen

Celgene

Ignyta

Merck KGaA

Nektar

Onxeo

PharmaMar

Spectrum Pharmaceuticals

National Health Institute

FEDER)

Government of Catalonia

International Association for the Study of Lung Cancer

European Society for Medical Oncology

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference16 articles.

1. A cancer family syndrome in 24 kindreds;Li;Cancer Res,1988

2. Revisiting Li-Fraumeni syndrome from TP53 mutation carriers;Bougeard;J Clin Oncol,2015

3. Li-Fraumeni syndrome: cancer risk assessment and clinical management;McBride;Nat Rev Clin Oncol,2014

4. Lung adenocarcinoma as part of the Li-Fraumeni syndrome spectrum: preliminary data of the LIFSCREEN randomized clinical trial;Caron;JAMA Oncol,2017

5. High prevalence of EGFR mutations in lung adenocarcinomas from Brazilian patients harboring the TP53 p.R337H variant;Barbosa;Clin Lung Cancer,2020

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung cancer screening in never smokers;Current Opinion in Oncology;2024-09-10

2. A dual biomarker in non-small cell lung cancer that predicts Li Fraumeni syndrome;Familial Cancer;2024-09-05

3. Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study;Lung Cancer;2024-08

4. EGFR-mutated lung cancer as a secondary neoplasm in a patient with Li-Fraumeni syndrome: case report;AME Case Reports;2024-07

5. p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications;Biomedicines;2024-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3